Somatostatin-Producing Neuroendocrine Tumor

subtype

Identifier: CI-CAN-00003998
Entity page: /cancer/somatostatin-producing-neuroendocrine-tumor ↗
Edges: 35

Neighbours: 16 drugs10 trials
Drawn: 26 of 26 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Somatostatin-Producing Neuroendocrine Tumor investigated for …INVESTIGATED_FOR4 of 4
← investigated for	Temsirolimussmall_molecule	unknown	2	Somatostatin-Producing Neuroendocrine Tumor	1	Curated	chembl	graph →
← investigated for	Bevacizumabmonoclonal_antibody	unknown	2

Somatostatin-Producing Neuroendocrine Tumor investigated in trials for …INVESTIGATED_IN_TRIALSderived14 of 14
→ investigated in trials for	Everolimussmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Somatostatin-Producing Neuroendocrine Tumor	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Temozolomidesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Somatostatin-Producing Neuroendocrine Tumor	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Capecitabinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Somatostatin-Producing Neuroendocrine Tumor	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Bevacizumabmonoclonal_antibody 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Somatostatin-Producing Neuroendocrine Tumor	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Pazopanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Somatostatin-Producing Neuroendocrine Tumor	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Cixutumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Somatostatin-Producing Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Dovitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Somatostatin-Producing Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Gefitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Somatostatin-Producing Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Regorafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Somatostatin-Producing Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Romidepsinother 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Somatostatin-Producing Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Sorafenib Tosylatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Somatostatin-Producing Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Temsirolimussmall_molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Somatostatin-Producing Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Vatalanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Somatostatin-Producing Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Veliparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Somatostatin-Producing Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →

Somatostatin-Producing Neuroendocrine Tumor investigated in trials for …INVESTIGATED_IN_TRIALSderived14 of 14

→ investigated in trials for

Everolimussmall molecule

4 trials (0 active) · roll-up of the cancer and its descendants

—

Somatostatin-Producing Neuroendocrine Tumor

Observed

Somatostatin-Producing Neuroendocrine Tumor studied in …STUDIED_INderived10 of 17show all (up to 200)
→ studied in	NCT01824875Phase 2 · completed Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors · condition mapped ALIAS · 17 trials mapped (0 active)	—	—	Somatostatin-Producing Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT00655655Phase 1 · completed Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors · condition mapped ALIAS · 17 trials mapped (0 active)	—	—	Somatostatin-Producing Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT01525082Phase 2 · completed Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors · condition mapped ALIAS · 17 trials mapped (0 active)	—	—	Somatostatin-Producing Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT02031536Phase 2 · terminated Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery · condition mapped ALIAS · 17 trials mapped (0 active)	—	—	Somatostatin-Producing Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT02259725Phase 2 · completed Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors · condition mapped ALIAS · 17 trials mapped (0 active)	—	—	Somatostatin-Producing Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT01869725Phase 2 · completed Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT · condition mapped ALIAS · 17 trials mapped (0 active)	—	—	Somatostatin-Producing Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT01465659Phase 1/Phase 2 · completed Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery · condition mapped ALIAS · 17 trials mapped (0 active)	—	—	Malignant Pancreatic Somatostatinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00454363Phase 2 · completed Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer · condition mapped ONTOLOGY_EXACT · 17 trials mapped (0 active)	—	—	Somatostatin-Producing Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT01010126Phase 2 · completed Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer · condition mapped ONTOLOGY_EXACT · 17 trials mapped (0 active)	—	—	Malignant Pancreatic Somatostatinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02831179Phase 1 · withdrawn Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor · condition mapped ONTOLOGY_EXACT · 17 trials mapped (0 active)	—	—	Somatostatin-Producing Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains